|
|
|
| The evidence gap in Hematology: From trial endpoints to patient outcomes | As hematology trials become more complex, sponsors face increasing pressure to accelerate development while generating stronger evidence, mitigating recruitment risk and supporting faster patient access. Join Parexel's experts to discover how RWD/RWE can help you make smarter decisions earlier, mitigate risk and strengthen your path from development to approval. Don't miss this opportunity — register today. |
|
|
|
| This Isn't Just A Compliance Exercise | Video | Clinical Leader Live | Natalie Monegro argues that representative enrollment is a scientific imperative, not merely a compliance exercise, and explains why sponsors need to show how trial data will be used to support real-world treatment and commercialization. |
|
|
| What To Know About The European Biotech Act | Article | Scout | EU-X-CT’s Biotech Act leaflet highlights cross-border trial access and the practical support patients need to travel, communicate, get reimbursed, and participate safely in another country. |
|
|
|
|
| Why Representation Is More Than A Diversity Checkbox | Video | Clinical Leader Live | Kemi Williams explains the distinction between diversity and representation, using the donanemab Alzheimer’s trial as an example of how underrepresentation can create real clinical and labeling consequences. |
|
|
| How Community-Based Research Models Expand Access | Article | By Miranda McLaren, EmVenio Clinical Research | As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's? |
|
|
|
| Recruitment Strategies: A Behind The Scenes Look | Brochure | CHDR | Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges. |
|
|
|
|
| Participant Payments: Navigating Modern Studies | White Paper | By Shaun Williams, IQVIA Technologies | To address the challenges of disbursing clinical trial participant payments globally, sponsors need region-specific payment solutions that navigate local laws and banking systems. |
|
|
| Connect With Clinical Leader: |
|
|
|
